## HOLX: Hologic, Inc. - XLV: Healthcare

### Executive Summary

No thesis match: MRS_10 2.9% below STRENGTH zone (3.0-6.0%); PEG 1.66 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($74.23)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 8, Bearish: 0)

**1. Hologic’s AI-Powered Mammography Technology Flagged a Third of Breast Cancer Cases Initially Interpreted as Negative in Study of 7,500 Screening Exams**
- Source: Business Wire | 20251216T130850 | Bullish | Relevance: 100%
- Hologic, Inc. announced new data showing its AI-powered mammography solution, Genius AI Detection, helped identify breast cancers initially missed in a study of 7,500 screening exams. The AI system flagged approximately one-third of false-negative cases and nearly 90% of previously identified cancers, accurately localizing suspicious areas. This study highlights AI's potential to improve breast cancer detection, especially for invasive ductal carcinomas.

**2. Hologic stock hits 52-week high at $75.14 By Investing.com**
- Source: Investing.com Australia | 20251215T150019 | Bullish | Relevance: 100%
- Hologic Inc (HOLX) stock recently hit a 52-week high of $75.14, marking a 3.67% increase over the past year. The medical technology company demonstrates strong financial health with moderate debt, an impressive Altman Z-Score, and low price volatility, trading slightly below its Fair Value according to InvestingPro. Recent news also highlights strong Q4 2025 results, expanded CE marking for its Genius Digital Diagnostics System in the EU, and upcoming presentations on its Breast Cancer Index Test.

**3. Hologic’s AI mammography tech flags previously missed breast cancers By Investing.com**
- Source: Investing.com Nigeria | 20251216T190837 | Bullish | Relevance: 100%
- Hologic, Inc. (NASDAQ:HOLX) announced new data showing its Genius AI Detection solution identified approximately one-third of previously missed breast cancers in a retrospective analysis. The AI system also flagged nearly 90% of previously identified breast cancer cases by radiologists, demonstrating significant potential for improving early detection. This innovation supports Hologic's strong financial performance, with the company reporting annual revenue of $4.1 billion.

**4. Hologic’s AI mammography tech flags previously missed breast cancers By Investing.com**
- Source: Investing.com Australia | 20251216T135541 | Bullish | Relevance: 100%
- Hologic, Inc. announced that its Genius AI Detection solution identified approximately one-third of previously missed breast cancers in a retrospective analysis. The AI system also accurately localized nearly 90% of previously identified breast cancer cases. This innovation contributes to Hologic's strong financial performance, with the company reporting annual revenue of $4.1 billion.

**5. Hologic’s AI-Powered Mammography Technology Flagged a Third of Breast Cancer Cases Initially Interpreted as Negative in Study of 7,500 Screening Exams**
- Source: The Joplin Globe | 20251216T130850 | Bullish | Relevance: 100%
- A new study published in the American Journal of Roentgenology reveals that Hologic's Genius AI Detection solution identified approximately one-third of breast cancer cases initially missed by radiologists in a retrospective analysis of 7,500 digital breast tomosynthesis screening exams. The AI technology accurately localized cancers that were later diagnosed, highlighting its potential to improve breast cancer detection. Hologic emphasizes its commitment to innovation in women's health with AI-powered solutions.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 16 ($0.27M) |
| Sells | 25 ($6.63M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 51.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 2 / 8 |

**Top Holders:**
- Vanguard Group Inc: 11.8% (-2.2%)
- T. Rowe Price Invest: 9.7% (-10.5%)
- Blackrock Inc.: 8.7% (-2.7%)
- Manufacturers Life I: 4.7% (-5.2%)
- State Street Corpora: 4.5% (-1.2%)

### Key Risks

1. Insider selling cluster: $6.6M in recent transactions.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_10 improving +3.4% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 1.66 elevated, pricing in significant growth expectations. Balance sheet: strong liquidity (3.5x). Insider selling cluster ($6.6M in 90 days), potential headwind. Institutional flow bullish (2 buying vs 8 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $16.7B |
| Beta | 0.70 |
| 52W Range | $51.90 - $75.34 |
| Short Interest | 2.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.66 |
| Forward P/E | 15.0 |
| Current P/E | 16.4 |
| YoY Growth | 9.6% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -0.5% to 2.9% (+3.4% in 5 days), confirming momentum buildup. Below STRENGTH zone by 0.1pp (needs >3.0% for momentum thesis). MRS_5 at 1.8% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: -SUN (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 2.87% (CS: 55) | Neutral |
| RSI_14 | 62.1 | Neutral |
| MACD Histogram | -0.12 | Bearish |
| vs SMA20 | 1.002x | Above |
| vs SMA50 | 1.022x | Above |
| vs SMA200 | 1.140x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $74.93
- **Stop Loss:** $74.23 (0.9% risk)
- **Target:** $75.63 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 1542
- **Position Value:** $115,542.06
- **Portfolio %:** 115.54%
- **Risk Dollars:** $1,080.00
- **Risk Per Trade:** 1.08%
- **Modifiers:** L1 90% | L2 120% | Combined 1.08x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | RISK_OFF (HIGH) | 0.90x |
| L2 Sector | TREND (Zone A) | 1.20x |

*RISK_OFF regime with deteriorating conditions. VIX rising to 17.6 (+11.7% over 5 days) signals increasing anxiety, while narrow breadth at 52.6% indicates selective participation. AI infrastructure cost concerns are pressuring tech leadership, creating sector rotation challenges in a late-cycle environment.*

### Earnings

**Next:** 2026-02-04 (Est: $1.10)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.10 | $1.13 | +2.7% |
| 2025Q2 | $1.05 | $1.08 | +2.7% |
| 2025Q1 | $1.02 | $1.03 | +1.4% |
| 2024Q4 | $1.02 | $1.03 | +1.4% |

---
*RULE-based L3 | 2026-01-07 01:40 | MRS_10*